Correlation Between CRISPR Therapeutics and Unity Software
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Unity Software at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Unity Software into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and Unity Software, you can compare the effects of market volatilities on CRISPR Therapeutics and Unity Software and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Unity Software. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Unity Software.
Diversification Opportunities for CRISPR Therapeutics and Unity Software
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between CRISPR and Unity is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Unity Software in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unity Software and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Unity Software. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unity Software has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Unity Software go up and down completely randomly.
Pair Corralation between CRISPR Therapeutics and Unity Software
If you would invest 4,080 in CRISPR Therapeutics AG on December 21, 2024 and sell it today you would earn a total of 0.00 from holding CRISPR Therapeutics AG or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
CRISPR Therapeutics AG vs. Unity Software
Performance |
Timeline |
CRISPR Therapeutics |
Unity Software |
CRISPR Therapeutics and Unity Software Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with CRISPR Therapeutics and Unity Software
The main advantage of trading using opposite CRISPR Therapeutics and Unity Software positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Unity Software can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unity Software will offset losses from the drop in Unity Software's long position.CRISPR Therapeutics vs. EBRO FOODS | CRISPR Therapeutics vs. Verizon Communications | CRISPR Therapeutics vs. Ribbon Communications | CRISPR Therapeutics vs. SBA Communications Corp |
Unity Software vs. BE Semiconductor Industries | Unity Software vs. GigaMedia | Unity Software vs. TOREX SEMICONDUCTOR LTD | Unity Software vs. Seven West Media |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Complementary Tools
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |